{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:28:05Z","timestamp":1773286085000,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG074899"],"award-info":[{"award-number":["R01AG074899"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL163814"],"award-info":[{"award-number":["R01HL163814"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019686","name":"Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006919","name":"Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.xpro.2024.103447","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:04:23Z","timestamp":1731672263000},"page":"103447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protocol for generation of PD modeling induced neurons and detection of \u03b1-synuclein forms"],"prefix":"10.1016","volume":"5","author":[{"given":"Francesco V.","family":"Nardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulimiheranmu","family":"Maisumu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraam M.","family":"Yakoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2024.103447_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100497","article-title":"Protocol for cell preparation and gene delivery in HEK293T and C2C12 cells","volume":"2","author":"Jiang","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xpro.2024.103447_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.xpro.2024.103447_bib3","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1111\/febs.14607","article-title":"Determinants of dopaminergic neuron loss in Parkinson's disease","volume":"285","author":"Surmeier","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.xpro.2024.103447_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12264-021-00775-9","article-title":"Glutamatergic Neurons in the Caudal Zona Incerta Regulate Parkinsonian Motor Symptoms in Mice","volume":"38","author":"Li","year":"2022","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.xpro.2024.103447_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41531-022-00314-x","article-title":"Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes","volume":"8","author":"Chegao","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.xpro.2024.103447_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coph.2014.10.011","article-title":"Targeting glutamatergic synapses in Parkinson's disease","volume":"20","author":"Gardoni","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.xpro.2024.103447_bib7","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","article-title":"Glucosylsphingosine Promotes alpha-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease","volume":"37","author":"Taguchi","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.xpro.2024.103447_bib8","doi-asserted-by":"crossref","first-page":"20760","DOI":"10.1073\/pnas.1903216116","article-title":"Cell models of lipid-rich alpha-synuclein aggregation validate known modifiers of alpha-synuclein biology and identify stearoyl-CoA desaturase","volume":"116","author":"Imberdis","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xpro.2024.103447_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fnins.2020.00442","article-title":"LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons","volume":"14","author":"Sanyal","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.xpro.2024.103447_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/mds.28346","article-title":"Upregulation of Cellular Palmitoylation Mitigates alpha-Synuclein Accumulation and Neurotoxicity","volume":"36","author":"Ho","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.xpro.2024.103447_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41531-022-00380-1","article-title":"Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous alpha-synuclein in human neurons","volume":"8","author":"Fonseca-Ornelas","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.xpro.2024.103447_bib12","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","article-title":"The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability","volume":"185","author":"Hallacli","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2024.103447_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13041-024-01086-6","article-title":"Mutant alpha-synuclein causes death of human cortical neurons via ERK1\/2 and JNK activation","volume":"17","author":"Suzuki","year":"2024","journal-title":"Mol. Brain"},{"key":"10.1016\/j.xpro.2024.103447_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41531-024-00725-y","article-title":"A stem cell-based assay platform demonstrates alpha-synuclein dependent synaptic dysfunction in patient-derived cortical neurons","volume":"10","author":"White","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.xpro.2024.103447_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2011.06.019","article-title":"Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations","volume":"146","author":"Soldner","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2024.103447_bib16","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1523\/JNEUROSCI.0896-06.2006","article-title":"Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates","volume":"26","author":"Mazzulli","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.xpro.2024.103447_bib17","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"alpha-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xpro.2024.103447_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","article-title":"Opportunities and challenges of alpha-synuclein as a potential biomarker for\u00a0Parkinson's disease and other synucleinopathies","volume":"8","author":"Magalhaes","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.xpro.2024.103447_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.852003","article-title":"Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies","volume":"13","author":"Menon","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.xpro.2024.103447_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in\u00a0Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xpro.2024.103447_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep14211","article-title":"Sensitive western blotting for detection of endogenous Ser129-phosphorylated alpha-synuclein in intracellular and extracellular spaces","volume":"5","author":"Sasaki","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xpro.2024.103447_bib22","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1074\/jbc.M112.403311","article-title":"In\u00a0vivo cross-linking reveals principally oligomeric forms of alpha-synuclein and beta-synuclein in neurons and non-neural cells","volume":"288","author":"Dettmer","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xpro.2024.103447_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081314","article-title":"A new method for quantitative immunoblotting of endogenous alpha-synuclein","volume":"8","author":"Newman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xpro.2024.103447_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fncel.2020.00159","article-title":"Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of alpha-Synuclein","volume":"14","author":"Guan","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.xpro.2024.103447_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: a new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xpro.2024.103447_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau4543","article-title":"Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of alpha-synuclein","volume":"12","author":"Harischandra","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xpro.2024.103447_bib27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/jnc.15147","article-title":"Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get","volume":"157","author":"Frey","year":"2021","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xpro.2024.103447_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/jnc.14806","article-title":"Cellular models of alpha-synuclein toxicity and aggregation","volume":"150","author":"Delenclos","year":"2019","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xpro.2024.103447_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100372","article-title":"Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue","volume":"2","author":"Stojkovska","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xpro.2024.103447_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-019-0095-3","article-title":"Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let's talk about the lipids in the room","volume":"5","author":"Killinger","year":"2019","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.xpro.2024.103447_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"alpha-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xpro.2024.103447_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13195-022-01150-0","article-title":"Alpha-synuclein: a pathological factor with Abeta and tau and biomarker in Alzheimer's disease","volume":"14","author":"Shim","year":"2022","journal-title":"Alzheimer's Res. Ther."}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166724006129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166724006129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T21:59:38Z","timestamp":1758837578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166724006129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2666166724006129"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2024.103447","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for generation of PD modeling induced neurons and detection of \u03b1-synuclein forms","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2024.103447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103447"}}